DHR

Danaher Schedules Third Quarter 2021 Earnings Conference Call

Tuesday, September 21, 2021 - 9:15pm

WASHINGTON, Sept. 21, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2021 on Thursday, October 21, 2021 beginning at 8:00 a.m.

Key Points: 
  • WASHINGTON, Sept. 21, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2021 on Thursday, October 21, 2021 beginning at 8:00 a.m.
  • You can access the conference call by dialing 800-895-3361 within the U.S. or +1 785-424-1062 outside the U.S. a few minutes before 8:00 a.m.
  • ET and notifying the operator that you are dialing in for Danaher's earnings conference call (Conference ID: DHRQ321).
  • A replay of the conference call will be available shortly after the conclusion of the call until November 4, 2021.

Discovery Harbour Drill Program Progressing Well on the Caldera Gold Property, Nevada

Tuesday, September 14, 2021 - 1:30pm

Vancouver, British Columbia--(Newsfile Corp. - September 14, 2021) - Discovery Harbour Resources Corp. (TSXV: DHR) (OTC Pink: DCHRF) (FSE: 4GW) (the "Company" or "Discovery Harbour") is pleased to announce that the Company's Caldera drill program is progressing well with four holes completed.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 14, 2021) - Discovery Harbour Resources Corp. (TSXV: DHR) (OTC Pink: DCHRF) (FSE: 4GW) (the "Company" or "Discovery Harbour") is pleased to announce that the Company's Caldera drill program is progressing well with four holes completed.
  • The Caldera gold property lies in a fertile gold region at the intersection of the Walker Lane and Northumberland Gold Belts northwest of Tonopah, Nevada.
  • Its current primary focus is the drill program on Caldera, a low sulphidation epithermal gold project in Nevada.
  • Additionally, Discovery Harbour has an agreement with Newcrest Mining Limited on its Fortuity 89 property in Nevada.

Danaher Announces Quarterly Dividends

Tuesday, September 14, 2021 - 9:15pm

WASHINGTON, Sept. 14, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.21 per share of its common stock, payable on October 29, 2021 to holders of record on September 30, 2021.

Key Points: 
  • WASHINGTON, Sept. 14, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.21 per share of its common stock, payable on October 29, 2021 to holders of record on September 30, 2021.
  • In addition, the Board of Directors has approved a quarterly cash dividend of $11.875 per share of its 4.75% Series A Mandatory Convertible Preferred Stock, payable on October 15, 2021 to holders of record on September 30, 2021.
  • The Board of Directors has also approved a quarterly cash dividend of $12.50 per share of its 5.00% Series B Mandatory Convertible Preferred Stock, payable on October 15, 2021 to holders of record on September 30, 2021.
  • Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world.

Demaris Mills Appointed President of IDT

Wednesday, September 1, 2021 - 5:14pm

CORALVILLE, Iowa, Sept. 1, 2021 /PRNewswire/ -- Integrated DNA Technologies (IDT) , a leading comprehensive genomics solutions provider, announced today that Demaris Mills has been appointed President of the Company, succeeding Trey Martin, who was promoted to a new position in Genomic Medicine within Danaher, IDT's parent company.

Key Points: 
  • CORALVILLE, Iowa, Sept. 1, 2021 /PRNewswire/ -- Integrated DNA Technologies (IDT) , a leading comprehensive genomics solutions provider, announced today that Demaris Mills has been appointed President of the Company, succeeding Trey Martin, who was promoted to a new position in Genomic Medicine within Danaher, IDT's parent company.
  • "I have admired IDT for many years, and I am thrilled and humbled to have this opportunity to lead such a storied and important company," Mills said.
  • Mills most recently served as President of Phenomenex, where she delivered above market growth through high-impact and sustainable improvements across the business, including innovation, commercial, operations, and people leadership.
  • Prior to Phenomenex, Mills delivered similarly transformative results at Beckman Coulter Life Sciences, as Vice President, General Manager of the Genomics and Liquid Handling businesses, Vice President of European Sales, Vice President of Global Marketing, and as leader of Product Management for the Leica Biosystems Consumables Business.

SCIEX Builds on Cadence of Innovation in Biopharma With Biologics Explorer

Wednesday, September 1, 2021 - 4:00pm

Biologics Explorer signifies the next step in innovation, building upon the ZenoTOF 7600 system , alongside Molecule Profiler .

Key Points: 
  • Biologics Explorer signifies the next step in innovation, building upon the ZenoTOF 7600 system , alongside Molecule Profiler .
  • The launch of the ZenoTOF 7600 system is the beginning of new possibilities for biopharmaceutical scientists and sets the pace for a cadence of innovation, said Mani Krishnan, VP GM, CE & Biopharma at SCIEX.
  • While Molecule Profiler extended the ZenoTOF 7600 systems capabilities into oligonucleotides, Biologics Explorer extends the reach once more, this time into protein therapeutics.
  • Biologics Explorer is built upon Genedata Expressionist, industry-leading enterprise software platform for biopharmaceutical mass spectrometry.

SCIEX Presents Industry First Multi-Capillary System for CE-SDS, the BioPhase 8800 System

Wednesday, September 1, 2021 - 4:00pm

SCIEX , a global leader in life science analytical technologies and Danaher operating company, presents the latest capillary electrophoresis solution, the BioPhase 8800 system.

Key Points: 
  • SCIEX , a global leader in life science analytical technologies and Danaher operating company, presents the latest capillary electrophoresis solution, the BioPhase 8800 system.
  • This is the only multi-capillary system for CE-SDS that processes eight samples simultaneously, retaining sample integrity and delivering consistent, accurate results.
  • The BioPhase 8800 system enables high throughput, sensitive CE-SDS and CIEF analysis, resulting in uncompromised accuracy for large sample sets.
  • With this system, scientists can quickly understand molecular liabilities and ensure the development and manufacture of robust, stable biologics.

Danaher Completes Acquisition of Aldevron

Monday, August 30, 2021 - 9:15pm

WASHINGTON, Aug. 30, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of Aldevron.

Key Points: 
  • WASHINGTON, Aug. 30, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of Aldevron.
  • As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
  • Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world.
  • Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets.

Danaher To Webcast Investor And Analyst Meeting

Wednesday, August 25, 2021 - 9:30pm

WASHINGTON, Aug. 25, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) will host a live video webcast of its Investor and Analyst Meeting on September 9, 2021 beginning at 12:00 p.m.

Key Points: 
  • WASHINGTON, Aug. 25, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) will host a live video webcast of its Investor and Analyst Meeting on September 9, 2021 beginning at 12:00 p.m.
  • The virtual event will be hosted by Rainer M. Blair, President and CEO of Danaher.
  • A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danaher's website, www.danaher.com , under the subheading "Events & Presentations."
  • Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world.

Danaher Announces Human Resources And Accounting Leadership Transition Plans

Tuesday, August 24, 2021 - 1:30pm

WASHINGTON, Aug. 24, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) (the "Company") today announced that, effectiveApril 1, 2022,Georgeann F. Coucharawill succeedAngela S. Lalor as Senior Vice President, Human Resources.

Key Points: 
  • WASHINGTON, Aug. 24, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) (the "Company") today announced that, effectiveApril 1, 2022,Georgeann F. Coucharawill succeedAngela S. Lalor as Senior Vice President, Human Resources.
  • Ms. Couchara, currently Vice President, Talent for the Company, will join the Danaher Leadership Team and the Office of the Chief Executive, reporting to Rainer M. Blair, Danaher's President & Chief Executive Officer.
  • I am confident that Georgeann will help shepherd Danaher into our next chapter while ensuring we meet our evolving global talent needs."
  • Previously, she led Human Resources for the Life Sciences companies of Danaher and, prior to that, at multiple Danaher operating companies.

Danaher Announces Passing of Former President & CEO, George M. Sherman

Friday, August 20, 2021 - 1:00pm

WASHINGTON, Aug. 20, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced that George M. Sherman, the Company's President & Chief Executive Officer during the years 1990-2001, died earlier this week after an illness.

Key Points: 
  • WASHINGTON, Aug. 20, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced that George M. Sherman, the Company's President & Chief Executive Officer during the years 1990-2001, died earlier this week after an illness.
  • Steven M. Rales, Danaher Chairman of the Board, commented: "All of us at Danaher are saddened by George's passing.
  • Mr. Rales continued: "George enjoyed an illustrious career at Danaher.
  • George led the transformation of Danaher's portfolio, principally through acquisitions, from a mix of fragmented businesses to strategically focused platforms.